Purchase Order 75N94025P00495

Award Date 8/18/25
Potential Completion Date 8/17/26
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Grand Island, NY 14072, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $134,032 purchase order to Life Technologies Corporation for laboratory equipment and supplies. As the prime contractor, Life Technologies will provide the requested materials to support NICHD's research efforts. Performance will take place at Life Technologies' facility in Grand Island, New York over a one year period concluding in July 2024. The firm fixed price contract was awarded without...
The National Institute of Child Health and Human Development (NICHD), a component of the Department of Health and Human Services' National Institutes of Health (NIH), has awarded a $11,041 purchase order to Quanterix Corporation of Billerica, Massachusetts. Under this firm fixed price contract running from August 2023 through August 2024, Quanterix will provide NICHD with supplies necessary for neurology testing, specifically a 2-plex biomarker assay kit to detect glial fibrillary acidic protein...
The National Institutes of Health's National Institute of Child Health and Human Development awarded a $24,597 purchase order to Luminex Corporation of Austin, Texas. Under the terms of the contract, Luminex will provide multiplexed bead assays to NICHD in support of the Institute's research efforts over the course of one year, from August 2023 through August 2024. As a leading manufacturer of multiplexed immunoassays using microsphere technology, Luminex is well positioned to deliver the...
The National Institute of Child Health and Human Development (NICHD) awarded a $42,378.13 firm fixed price purchase order to Life Technologies Corporation, a for-profit manufacturer of scientific instruments and consumables. The contract is for the supply of a QuantStudio 5 Real-Time PCR System to support NICHD's research on gene expression in human induced pluripotent stem cells. This sole source award was made under FAR Simplified Acquisition Procedures without a set-aside designation. Life...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $13,815.36 firm fixed-price purchase order to Life Technologies Corporation of Bethesda, Maryland. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, will provide products or services to the NIH NICHD under this contract running from March 15 to March 21, 2016. The award was made using an unspecified...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $32,445 firm fixed price purchase order to Life Technologies Corporation of Carlsbad, California. As a subsidiary of Thermo Electron Corporation Financial Services Division, Life Technologies will provide products or services to NIH under this contract through September 30, 2016 in support of NICHD's research efforts. No additional details were provided on...
The National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services, awarded a $4,014.72 firm fixed-price purchase order to Life Technologies Corporation, a division of Thermo Fisher Scientific, for a 7500 Fast Real-Time PCR System. The award does not have a set-aside designation. Life Technologies is a leading manufacturer of scientific instruments, reagents, and consumables that supports federal research initiatives...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $6,694 purchase order to Meso Scale Discovery of Bethesda, Maryland. Under the firm fixed price contract, Meso Scale Discovery will provide a Proinflammatory Panel 1 Kit to support the NIH NICHD's biomedical research efforts. The one-year contract runs from September 12, 2017 through March 11, 2018 and calls for the delivery of assay products to the...
The Department of Health and Human Services' National Institutes of Health's National Institute of Child Health and Human Development awarded a $5,000 purchase order to Proteinsimple, a division of Bio-Techne Corporation doing business as Bio-Techne, to provide unspecified services. The one-year contract runs from December 2016 through December 2017 and utilizes a firm fixed price payment structure. The place of performance is Bethesda, Maryland, where NICHD is headquartered. No additional...
The Department of Health and Human Services' National Institutes of Health National Institute of Child Health and Human Development awarded a $74,507.52 purchase order to Life Technologies Corporation for ION PI sequencing 200 kits and related items. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, will deliver the requested products and services from its location in Bethesda, Maryland by August 1, 2014 to support the NIH NICHD's research...

The National Institute of Child Health and Human Development (NICHD), part of the Department of Health and Human Services, awarded a $25,376.40 firm-fixed-price purchase order to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., for the supply of three units of ProcartaPlex HU IMMUNE RESPONSE 80PLEX 96 TESTS immunoassay plates compatible with the Luminex xMAP INTELLIFLEX platform. This acquisition supports the NICHD's research capabilities in high-throughput multiplex protein expression analysis, enabling the detection of up to 80 different proteins or gene expression markers in a single assay using limited sample volumes. The procurement was conducted as a Request for Quotation under Simplified Acquisition Procedures and did not utilize any set-aside designations. The contract has an ultimate completion date of August 17, 2026.

Generated 8/14/25, 10:03 AM